Inventor · disambiguated record
Makiko Yasuda
Also filed as: YASUDA MAKIKO
6 granted patents·8 pending applications·36 citations·filing 2013–2024
83Inventor score
Top patents by PatentIndex Score
14 records- 0195US9133461B2Compositions and methods for inhibiting expression of the ALAS1 geneALNYLAM PHARMACEUTICALS INC·Filed 2013·Granted Sep 15, 2015·19 cites·58 claims
- 0290US9631193B2Compositions and methods for inhibiting expression of the ALAS1 geneALNYLAM PHARMACEUTICALS INC·Filed 2013·Granted Apr 25, 2017·8 cites·45 claims
- 0388US2025034566A1Compositions and methods for inhibiting expression of the alas1 geneALNYLAM PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0487US10400239B2Compositions and methods for inhibiting expression of the ALAS1 geneALNYLAM PHARMACEUTICALS INC·Filed 2017·Granted Sep 3, 2019·3 cites·51 claims
- 0587US2024254486A1Compositions and methods for inhibiting expression of the alas1 geneALNYLAM PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0686US11028392B2Compositions and methods for inhibiting expression of the ALAS1 geneALNYLAM PHARMACEUTICALS INC·Filed 2018·Granted Jun 8, 2021·1 cites·37 claims
- 0784US10125364B2Compositions and methods for inhibiting expression of the ALAS1 geneALNYLAM PHARMACEUTICALS INC·Filed 2015·Granted Nov 13, 2018·2 cites·36 claims
- 0884US2025122505A1Compositions and methods for inhibiting expression of the alas1 geneALNYIAM PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0981US10119143B2Compositions and methods for inhibiting expression of the ALAS1 geneALNYLAM PHARMACEUTICALS INC·Filed 2014·Granted Nov 6, 2018·3 cites·78 claims
- 1078US2020181614A1Compositions and methods for inhibiting expression of the alas1 geneALNYLAM PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1177US2022403382A1Compositions and methods for inhibiting expression of the alas1 geneALNYLAM PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1274US2021087558A1Compositions and methods for inhibiting expression of the alas1 geneALNYLAM PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1374US2023026968A1Compositions and methods for inhibiting expression of the alas1 geneALNYLAM PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1469US2019218549A1Compositions and methods for inhibiting expression of the alas1 geneALNYLAM PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Makiko Yasuda files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →